The Role of Auditory Feedback in Guiding Upper Extremity Movements
NCT ID: NCT02100306
Last Updated: 2014-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
26 participants
INTERVENTIONAL
2014-05-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that patients who receive less feedback (50% alternate) will have enhanced learning relative to the patients who receive more feedback (100%).
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients will receive:
Auditory Feedback 100% Auditory Feedback 50% alternate
Auditory Feedback 100%
Patients will receive constant auditory feedback across training trials.
Auditory Feedback 50% alternate
Patients will receive alternating auditory feedback (1 trial auditory feedback; 1 trial no auditory feedback) across trials
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auditory Feedback 100%
Patients will receive constant auditory feedback across training trials.
Auditory Feedback 50% alternate
Patients will receive alternating auditory feedback (1 trial auditory feedback; 1 trial no auditory feedback) across trials
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke patients should have some movement of shoulder/elbow (no movement of hand - e.g. hand, fingers - is OK)
* \> 2 months post
* between 30-85 years
Exclusion Criteria
* severe comprehension (or cognitive) deficit that compromises informed consent or understanding of instructions
* contraindications to MRI (e.g. claustrophobia, metal implants)
* neurodegenerative or psychiatric disease
* apraxia
* auditory deficits that would impair testing
* prior musculoskeletal injury to back or upper extremity (including shoulder subluxation from stroke)
* skin conditions that would preclude taping of goniometers
30 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnybrook Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joyce Chen, PhD
Role: PRINCIPAL_INVESTIGATOR
Canadian Partnership for Stroke Recovery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JCH-1234-SF
Identifier Type: -
Identifier Source: org_study_id